A protein known as arginine methyltransferase 1 (PRMT1) may be a potential therapeutic target for pancreatic ductal adenocarcinoma (PDAC), the most common type of pancreatic cancer, and one of the most deadliest with a less than 10 percent, five-year survival rate. PRMT1 is involved in a number of genetic processes including gene transcription, DNA repair and signaling.
from Top Health News – ScienceDaily http://ift.tt/2o8KQgr
from Tumblr http://ift.tt/2nhqVYu
No comments:
Post a Comment